Glycaemic Control is Correlated with Well-Being Index (WHO-5) in Subjects with Type 2 Diabetes

Abstract

The aim of this study was to examine the potential correlation of WHO-5 well-being index with glycaemic control and chronic complications in subjects with type 2 diabetes. The study included 156 subjects (73 men, mean age 64.05±9.11 years, mean diabetes duration 12.22±5.61 years). Well-being was assessed by the WHO-5 score via a validated questionnaire comprising 5 questions (Q1-Q5). HbA_1c showed a significant negative correlation with overall WHO-5 score (r_s=−0.248, p=0.002) and individual Q1–Q4 scores (r_s=−0.262, p=0.001; r_s=−0.248, p=0.002; r_s=−0.207, p=0.009 and r_s=−0.169, p=0.035 respectively). Subjects with adequate glycaemic control (HbA_1c < 7%, n=67) had a significantly higher WHO-5 score in comparison to those with inadequate glycaemic control (HbA_1c ≥ 7%, n=89) (mean±SD: 19.69±5.47 vs. mean±SD: 17.11±6.38, p=0.011). Finally, WHO-5 score was significantly (p=0.013) lower in subjects with neuropathic pain than in those without neuropathic pain. Conclusions: In type 2 diabetic subjects, glycaemic control shows a significant correlation with well-being, while neuropathic pain is associated with lower well-being score.

Key words

diabetes mellitus - quality of life - glycaemic control - WHO-5 - neuropathic pain

References

• 1 Apostolou T, Hutchison AJ, Boulton AJ. et al . Quality of life in CAPD, transplant, and chronic renal failure patients with diabetes.  Ren Fail. 2007;  29 189-197
• 2 Armstrong DG, Lavery LA, Wrobel JS. et al . Quality of life in healing diabetic wounds: does the end justify the means?.  J Foot Ankle Surg. 2008;  47 278-282
• 3 Awata S, Bech P, Yoshida S. et al . Reliability and validity of the Japanese version of the World Health Organization-Five Well-Being Index in the context of detecting depression in diabetic patients.  Psychiatry Clin Neurosci. 2007;  61 112-119
• 4 Bech P, Olsen LR, Kjoller M. et al . Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale.  Int J Methods Psychiatr Res. 2003;  12 85-91
• 5 Blackburn H, Keys A, Simonson E. et al . The electrocardiogram in population studies. A classification system.  Circulation. 1960;  21 1160-1175
• 6 Bloomgarden ZT. Diabetes complications.  Diabetes Care. 2004;  27 1506-1514
• 7 Bloomgarden ZT. Cardiovascular disease in diabetes.  Diabetes Care. 2008;  31 1260-1266
• 8 Chobanian AV, Bakris GL, Black HR. et al . The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.  JAMA. 2003;  289 2560-2572
• 9 de Wit M, Pouwer F, Gemke RJ. et al . Validation of the WHO-5 Well-Being Index in adolescents with type 1 diabetes.  Diabetes Care. 2007;  30 2003-2006
• 10 de Wit M, Delemarre-van de Waal HA, Bokma JA. et al . Self-report and parent-report of physical and psychosocial well-being in Dutch adolescents with type 1 diabetes in relation to glycemic control.  Health Qual Life Outcomes. 2007b;  5 10
• 11 Eren I, Erdi O, Sahin M. The effect of depression on quality of life of patients with type II diabetes mellitus.  Depress Anxiety. 2008;  25 98-106
• 12 Fong DS, Aiello L, Gardner TW. et al . Diabetic retinopathy.  Diabetes Care. 2003;  26 ((Suppl 1)) S99-S102
• 13 Garber AJ, Wahlen J, Wahl T. et al . Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).  Diabetes Obes Metab. 2006;  8 58-66
• 14 Garratt AM, Schmidt L, Fitzpatrick R. Patient-assessed health outcome measures for diabetes: a structured review.  Diabet Med. 2002;  19 1-11
• 15 Goykhman S, Drincic A, Desmangles JC. et al . Insulin Glargine: a review 8 years after its introduction.  Expert Opin Pharmacother. 2009;  10 705-718
• 16 Gumprecht J, Benroubi M, Borzi V. et al . Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE observational study.  Int J Clin Pract. 2009;  63 966-972
• 17 Hajos TRS, Pouwer F, de Grooth R. et al . Improves symptom distress and well-being following initiation of insulin glargine in suboptimally controlled type 2 diabetes patients on oral agents. An observational study.  Diabetologia. 2009;  52 ((Suppl 1)) A 973
• 18 Ismail K, Winkley K, Rabe-Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes.  Lancet. 2004;  363 1589-1597
• 19 Klein S, Hage JJ. Measurement, calculation, and normal range of the ankle-arm index: a bibliometric analysis and recommendation for standardization.  Ann Vasc Surg. 2006;  20 282-292
• 20 Logtenberg SJ, van Ballegooie E, Israel-Bultman H. et al . Glycaemic control, health status and treatment satisfaction with continuous intraperitoneal insulin infusion.  Neth J Med. 2007;  65 65-70
• 21 Molitch ME, DeFronzo RA, Franz MJ. et al . Diabetic nephropathy.  Diabetes Care. 2003;  26 ((Suppl 1)) S94-S98
• 22 Papanas N, Papatheodorou K, Papazoglou D. et al . Foot temperature in type 2 diabetic patients with or without peripheral neuropathy.  Exp Clin Endocrinol Diabetes. 2009;  117 44-47
• 23 Rosen RC, Riley A, Wagner G. et al . The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.  Urology. 1997;  49 822-830
• 24 Shea S, Skovlund S, Bech P. et al . Routine assessment of psychological well-being in people with diabetes in primary care – validation of the WHO-5-Well-being-Index in six countries.  Diabetologia. 2003;  46 A88
• 25 Tan SM, Shafiee Z, Wu LL. et al . Factors associated with control of type I diabetes in Malaysian adolescents and young adults.  Int J Psychiatry Med. 2005;  35 123-136
• 26 Tsapas A, Matthews DR. N of 1 trials in diabetes: making individual therapeutic decisions.  Diabetologia. 2008;  51 921-925
• 27 Vileikyte L, Peyrot M, Bundy C. et al . The development and validation of a neuropathy- and foot ulcer-specific quality of life instrument.  Diabetes Care. 2003;  26 2549-2555
• 28 Vileikyte L, Leventhal H, Gonzalez JS. et al . Diabetic peripheral neuropathy and depressive symptoms: the association revisited.  Diabetes Care. 2005;  28 2378-2383
• 29 Vileikyte L, Peyrot M, Gonzalez JS. et al . Predictors of depressive symptoms in persons with diabetic peripheral neuropathy: a longitudinal study.  Diabetologia. 2009;  52 1265-1273
• 30 Wild S, Roglic G, Green A. et al . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.  Diabetes Care. 2004;  27 1047-1053
• 31 Winkley K, Ismail K, Landau S. et al . Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of randomised controlled trials.  BMJ. 2006;  333 65
• 32 Young MJ, Boulton AJ, MacLeod AF. et al . A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population.  Diabetologia. 1993;  36 150-154
• 33 Ziegler D. Painful diabetic neuropathy: treatment and future aspects.  Diabetes Metab Res Rev. 2008;  24 ((Suppl 1)) S52-S57

Correspondence